Published in Appl Health Econ Health Policy on January 01, 2008
Estimation of benefit of prevention of occupational cancer for comparative risk assessment: methods and examples. Occup Environ Med (2012) 1.01
Lifetime costs of the top five cancers in Taiwan. Eur J Health Econ (2011) 0.90
Prolactin promotes hepatocellular carcinoma through Janus kinase 2. World J Surg (2012) 0.88
Patterns of treatment and costs of intermediate and advanced hepatocellular carcinoma management in four Italian centers. Ther Clin Risk Manag (2015) 0.75
MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis. J Clin Invest (2012) 3.46
Comprehensive analysis of the independent effect of twist and snail in promoting metastasis of hepatocellular carcinoma. Hepatology (2009) 3.42
Concurrent chemoradiotherapy treatment of locally advanced pancreatic cancer: gemcitabine versus 5-fluorouracil, a randomized controlled study. Int J Radiat Oncol Biol Phys (2003) 2.25
Prognostic significance of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin in patients with resectable hepatocellular carcinoma after surgery. Ann Surg Oncol (2003) 2.08
Impact of radiotherapy for pediatric CNS atypical teratoid/rhabdoid tumor (single institute experience). Int J Radiat Oncol Biol Phys (2006) 2.03
Cytochrome P450 2E1 genotype and the susceptibility to antituberculosis drug-induced hepatitis. Hepatology (2003) 1.92
Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatitis. Hepatology (2002) 1.64
Differential mechanism and prognostic impact of diabetes mellitus on patients with hepatocellular carcinoma undergoing surgical and nonsurgical treatment. Am J Gastroenterol (2004) 1.63
Pre-operative chemoradiotherapy with oral tegafur-uracil and leucovorin for rectal cancer. J Surg Oncol (2005) 1.55
Depression is the strongest independent risk factor for poor social engagement among Chinese elderly veteran assisted-living residents. J Chin Med Assoc (2009) 1.49
Factors associated with prolonged hospital stay for acute stroke in Taiwan. Acta Neurol Taiwan (2008) 1.46
Characteristics of autoimmune hepatitis in Taiwan: the 11 years' experiences of a medical center. Zhonghua Yi Xue Za Zhi (Taipei) (2002) 1.45
HCV NS5A interacts with p53 and inhibits p53-mediated apoptosis. Oncogene (2002) 1.43
Magnetic resonance angiography in reversible cerebral vasoconstriction syndromes. Ann Neurol (2010) 1.42
Primary pediatric brain tumors: statistics of Taipei VGH, Taiwan (1975-2004). Cancer (2005) 1.42
Secular trends and geographic variations of hepatitis B virus and hepatitis C virus-associated hepatocellular carcinoma in Taiwan. Int J Cancer (2006) 1.40
A comparison of prognosis between patients with hepatitis B and C virus-related hepatocellular carcinoma undergoing resection surgery. World J Surg (2011) 1.29
A phase III study of adjuvant chemotherapy in advanced nasopharyngeal carcinoma patients. Int J Radiat Oncol Biol Phys (2002) 1.28
Genotypes and viremia of hepatitis B and D viruses are associated with outcomes of chronic hepatitis D patients. Gastroenterology (2006) 1.22
MicroRNA let-7a represses chemoresistance and tumourigenicity in head and neck cancer via stem-like properties ablation. Oral Oncol (2011) 1.18
Treatment of spinal cord ependymomas by surgery with or without postoperative radiotherapy. J Neurooncol (2005) 1.15
Resistance to tamoxifen-induced apoptosis is associated with direct interaction between Her2/neu and cell membrane estrogen receptor in breast cancer. Int J Cancer (2002) 1.14
Survival rates are comparable after radiofrequency ablation or surgery in patients with small hepatocellular carcinomas. Clin Gastroenterol Hepatol (2010) 1.12
Hepatitis C virus NS5A as a potential viral Bcl-2 homologue interacts with Bax and inhibits apoptosis in hepatocellular carcinoma. Int J Cancer (2003) 1.11
Practical difficulties in the management of hepatitis B in the Asia-Pacific region. J Gastroenterol Hepatol (2004) 1.09
Thrombocytosis: a paraneoplastic syndrome in patients with hepatocellular carcinoma. World J Gastroenterol (2004) 1.08
HCV NS5A inhibits interferon-alpha signaling through suppression of STAT1 phosphorylation in hepatocyte-derived cell lines. J Hepatol (2006) 1.06
Comparison of recurrence after hepatic resection in patients with hepatitis B vs. hepatitis C-related small hepatocellular carcinoma in hepatitis B virus endemic area. Liver Int (2005) 1.06
Risk of hepatic failure after transcatheter arterial chemoembolization for hepatocellular carcinoma: predictive value of the monoethylglycinexylidide test. Am J Gastroenterol (2002) 1.05
The Influence of Hepatitis B Viral Load and Pre-S Deletion Mutations on Post-Operative Recurrence of Hepatocellular Carcinoma and the Tertiary Preventive Effects by Anti-Viral Therapy. PLoS One (2013) 1.05
Epidemiology of upper urinary tract stone disease in a Taiwanese population: a nationwide, population based study. J Urol (2013) 1.05
Hepatic resection can provide long-term survival of patients with non-early-stage hepatocellular carcinoma: extending the indication for resection? Surgery (2012) 1.04
Diabetes mellitus is a risk factor for hepatic decompensation in patients with hepatocellular carcinoma undergoing resection: a longitudinal study. Am J Gastroenterol (2003) 1.04
Proposal of a modified Child-Turcotte-Pugh scoring system and comparison with the model for end-stage liver disease for outcome prediction in patients with cirrhosis. Liver Transpl (2006) 1.02
Clinical characteristics and prognosis of hepatocellular carcinoma patients with paraneoplastic syndromes. Hepatogastroenterology (2002) 1.01
Polymorphism of the N-acetyltransferase 2 gene, red meat intake, and the susceptibility of hepatocellular carcinoma. Am J Gastroenterol (2003) 1.00
The model for end-stage liver disease based cancer staging systems are better prognostic models for hepatocellular carcinoma: a prospective sequential survey. Am J Gastroenterol (2007) 1.00
The effect of age on the long-term prognosis of patients with hepatocellular carcinoma after resection surgery: a propensity score matching analysis. Arch Surg (2011) 0.99
Younger hepatocellular carcinoma patients have better prognosis after percutaneous radiofrequency ablation therapy. J Clin Gastroenterol (2012) 0.98
Design and development of interface design principles for complex documentation using PDAs. Comput Inform Nurs (2011) 0.98
Varied assembly and RNA editing efficiencies between genotypes I and II hepatitis D virus and their implications. Hepatology (2002) 0.98
Evaluation of predictive value of CLIP, Okuda, TNM and JIS staging systems for hepatocellular carcinoma patients undergoing surgery. J Gastroenterol Hepatol (2005) 0.96
Fibrosis and AST to platelet ratio index predict post-operative prognosis for solitary small hepatitis B-related hepatocellular carcinoma. Hepatol Int (2010) 0.96
Change in treatment strategy for intracranial germinoma: long-term follow-up experience at a single institute. Cancer (2011) 0.96
Incidence and risk factors for acute renal failure in patients with hepatocellular carcinoma undergoing transarterial chemoembolization: a prospective study. Liver Int (2004) 0.96
[Genetic characteristics of HIV-1 CRF01_AE strains in four provinces, southern China]. Zhonghua Liu Xing Bing Xue Za Zhi (2009) 0.95
Identification of novel HLA-A*0201-restricted CD8+ T-cell epitopes on hepatitis delta virus. J Gen Virol (2004) 0.95
Chemotherapy with etoposide, doxorubicin, cisplatin, 5-fluorouracil, and leucovorin for patients with advanced hepatocellular carcinoma. Med Oncol (2007) 0.91
Lifetime costs of the top five cancers in Taiwan. Eur J Health Econ (2011) 0.90
Risk factors for long-term prognosis in hepatocellular carcinoma after radiofrequency ablation therapy: the clinical implication of aspartate aminotransferase-platelet ratio index. Eur J Gastroenterol Hepatol (2011) 0.90
Diabetes mellitus is a recurrence-independent risk factor in patients with hepatitis B virus-related hepatocellular carcinoma undergoing resection. Eur J Gastroenterol Hepatol (2003) 0.89
Risk of oral antifungal agent-induced liver injury in Taiwanese. Br J Clin Pharmacol (2014) 0.89
Inverse association between hepatitis B virus infection and fatty liver disease: a large-scale study in populations seeking for check-up. PLoS One (2013) 0.88
Molecular epidemiological and clinical aspects of hepatitis D virus in a unique triple hepatitis viruses (B, C, D) endemic community in Taiwan. J Med Virol (2003) 0.88
Enhancement of radiosensitivity in human glioblastoma cells by the DNA N-mustard alkylating agent BO-1051 through augmented and sustained DNA damage response. Radiat Oncol (2011) 0.88
Percutaneous ablation therapy for hepatocellular carcinoma: current practice and future perspectives. J Chin Med Assoc (2005) 0.88
Hepatitis B surface antigen levels and sequences of natural hepatitis B virus variants influence the assembly and secretion of hepatitis d virus. J Virol (2007) 0.87
Definition of three minimal deleted regions by comprehensive allelotyping and mutational screening of FHIT,p16(INK4A), and p19(ARF) genes in nasopharyngeal carcinoma. Cancer (2002) 0.87
Validation of EQ-5D in patients with cervical cancer in Taiwan. Support Care Cancer (2009) 0.87
X protein of hepatitis B virus functions as a transcriptional corepressor on the human telomerase promoter. Hepatology (2007) 0.86
Serum interferon gamma level predicts recurrence in hepatocellular carcinoma patients after curative treatments. Int J Cancer (2013) 0.86
Systemic amyloidosis manifesting as a rare cause of hepatic failure. J Chin Med Assoc (2010) 0.86
Risk of hepato-biliary cancer after cholecystectomy: a nationwide cohort study. J Gastrointest Surg (2012) 0.86
Predicting mortality of older residents in long-term care facilities: comorbidity or care problems? J Am Med Dir Assoc (2010) 0.86
A DNA vaccine against cytotoxic T-lymphocyte associated antigen-4 (CTLA-4) prevents tumor growth. Biochem Biophys Res Commun (2013) 0.86
Seroprevalence of hepatitis E virus infection among institutionalized psychiatric patients in Taiwan. J Clin Virol (2006) 0.86
Proposal of a modified Cancer of the Liver Italian Program staging system based on the model for end-stage liver disease for patients with hepatocellular carcinoma undergoing loco-regional therapy. Am J Gastroenterol (2006) 0.85
Natural history and prognostic factors of primary biliary cirrhosis in Taiwan: a follow-up study up to 18 years. Liver Int (2008) 0.85
Survival impact of delayed treatment in patients with hepatocellular carcinoma undergoing locoregional therapy: is there a lead-time bias? Scand J Gastroenterol (2007) 0.85
Inpatient rehabilitation utilization for acute stroke under a universal health insurance system. Am J Manag Care (2010) 0.85
Survival benefit of cirrhotic patients with hepatocellular carcinoma treated by percutaneous ethanol injection as a salvage therapy. Scand J Gastroenterol (2002) 0.85
Efficacy and factors affecting outcome of gemcitabine concurrent chemoradiotherapy in patients with locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys (2008) 0.85
Treatment strategies for initially disseminated intracranial germinomas: experiences at a single institute. Childs Nerv Syst (2012) 0.84
Application of serologic assays for diagnosing acute hepatitis E in national surveillance of a nonendemic area. J Med Virol (2014) 0.84
Prognostic significance of computed tomography scan-derived splenic volume in hepatocellular carcinoma treated with radiofrequency ablation. J Clin Gastroenterol (2012) 0.84
Impact of body mass index and viral load on liver histology in hepatitis B e antigen-negative chronic hepatitis B. Clin Nutr (2011) 0.84
Changing seroepidemiology of hepatitis B, C, and D virus infections in high-risk populations. J Med Virol (2004) 0.84
Limitation of the model for end-stage liver disease for outcome prediction in patients with cirrhosis-related complications. Clin Transplant (2006) 0.84
Predictive value of aspartate aminotransferase to alanine aminotransferase ratio for hepatic fibrosis and clinical adverse outcomes in patients with primary biliary cirrhosis. J Clin Gastroenterol (2009) 0.84
Occurrence of cirrhosis-related complications is a time-dependent prognostic predictor independent of baseline model for end-stage liver disease score. Liver Int (2006) 0.84
Clinical correlates and diagnostic utility of osmophobia in migraine. Cephalalgia (2012) 0.84
Dementia care costs and the patient's quality of life (QoL) in Taiwan: home versus institutional care services. Arch Gerontol Geriatr (2009) 0.84
Germinoma involving the basal ganglia in children. Childs Nerv Syst (2007) 0.84
Fever after transcatheter arterial chemoembolization for hepatocellular carcinoma: incidence and risk factor analysis. Scand J Gastroenterol (2008) 0.83
Surgeon volume for percutaneous nephrolithotomy is associated with medical costs and length of hospital stay: a nationwide population-based study in Taiwan. J Endourol (2014) 0.83
Pediatric urolithiasis in Taiwan: a nationwide study, 1997-2006. Urology (2012) 0.83
Varied immunity generated in mice by DNA vaccines with large and small hepatitis delta antigens. J Virol (2003) 0.83
Prognosis of Early-Stage Hepatocellular Carcinoma: The Clinical Implications of Substages of Barcelona Clinic Liver Cancer System Based on a Cohort of 1265 Patients. Medicine (Baltimore) (2015) 0.83
Mutant Bik gene transferred by cationic liposome inhibits peritoneal disseminated murine colon cancer. Clin Exp Metastasis (2007) 0.83
Multiple effects of Honokiol on the life cycle of hepatitis C virus. Liver Int (2011) 0.83
Hepatocellular carcinoma with presentation of budd-Chiari syndrome. J Chin Med Assoc (2010) 0.83
Interaction and replication activation of genotype I and II hepatitis delta antigens. J Virol (2004) 0.83
Concurrence of UGT1A polymorphism and end-stage renal disease leads to severe toxicities of irinotecan in a patient with metastatic colon cancer. Tumori (2011) 0.82
The association of RAB18 gene polymorphism (rs3765133) with cerebellar volume in healthy adults. Cerebellum (2014) 0.82
Comparison of four model for end-stage liver disease-based prognostic systems for cirrhosis. Liver Transpl (2008) 0.82
Differential roles of serum hepatitis B virus DNA and hepatitis B surface antigen level in predicting virological breakthrough in patients receiving lamivudine therapy. J Gastroenterol Hepatol (2013) 0.82